6:46 AM ET
10-Q
Financial Results
Acurx Pharmaceuticals Q3 2026 Results: Net Loss of $2.58M, Loss Widens
Acurx Pharmaceuticals reported a net loss of $6.5 million for the nine months ended September 30, 2026, compared to $6.4 million in the prior year period. The company strengthened its cash position to $9.7 million following equity issuances, while research and development expenses increased significantly in the third quarter to $1.1 million.
- Key figure
- Net loss $2.58M